|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | C07K 16/3061 | (2013.01) |
| A61K 35/17 | (2015.01) | ||
| A61K 39/395 | (2006.01) | ||
| A61K2039/505 | (2013.01) | ||
| C07K 14/725 | (2006.01) | ||
| A61K2300/00 | (2013.01) | ||
| C12N 5/0783 | (2010.01) | ||
| C07K2317/622 | (2013.01) | ||
| A61P 35/00 | (2006.01) | ||
| C07K2317/73 | (2013.01) | ||
| C07K2319/33 | (2013.01) | ||
| A61K 31/7076 | (2013.01) | ||
| A61K 31/664 | (2013.01) | ||
| A61K 39/3955 | (2013.01) | ||
| A61P 35/00 | (2018.01) | ||
| A61K 38/1774 | (2013.01) | ||
| A61K 38/177 | (2013.01) | ||
| C07K 16/2893 | (2013.01) | ||
| C07K2319/03 | (2013.01) | ||
| C07K 16/2803 | (2013.01) | ||
| A61K 39/4631 | (2023.05) | ||
| A61K 39/001102 | (2018.08) | ||
| C12N 5/0636 | (2013.01) | ||
| A61K2239/38 | (2023.05) | ||
| A61K 39/4611 | (2023.05) | ||
| A61K 39/464412 | (2023.05) | ||
| A61K2239/31 | (2023.05) | ||
| A61K2239/48 | (2023.05) | ||
| A61K2239/26 | (2023.05) | ||
| A61K2239/23 | (2023.05) |
| (11) | Number of the document | 3703710 |
| (13) | Kind of document | T |
| (96) | European patent application number | 18804466.3 |
| Date of filing the European patent application | 2018-10-30 | |
| (97) | Date of publication of the European application | 2020-09-09 |
| (45) | Date of publication and mention of the grant of the patent | 2024-08-07 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2018/058288 |
| Date | 2018-10-30 |
| (87) | Number | WO 2019/089650 |
| Date | 2019-05-09 |
| (30) | Number | Date | Country code |
| 201762579426 P | 2017-10-31 | US | |
| 201862716898 P | 2018-08-09 | US | |
| 201862750215 P | 2018-10-24 | US |
| (72) |
KONTO, Cyril Alkis , US
ZINAI, Amina , FR
|
| (73) |
Allogene Therapeutics, Inc. ,
210 E. Grand Avenue, South San Francisco, CA 94080,
US
Les Laboratoires Servier , 35, rue de Verdun, 92284 Suresnes Cedex, FR |
| (54) | METHODS AND COMPOSITIONS FOR DOSING OF ALLOGENEIC CHIMERIC ANTIGEN RECEPTOR T CELLS FOR TREATING REFRACTORY AND/OR RELAPSED LARGE B-CELL LYMPHOMA OR REFRACTORY AND/OR RELAPSED FOLLICULAR LYMPHOMA |
| METHODS AND COMPOSITIONS FOR DOSING OF ALLOGENEIC CHIMERIC ANTIGEN RECEPTOR T CELLS FOR TREATING REFRACTORY AND/OR RELAPSED LARGE B-CELL LYMPHOMA OR REFRACTORY AND/OR RELAPSED FOLLICULAR LYMPHOMA |